Latest Breaking News On - Gossamer bio - Page 17 : comparemela.com

12 Best Penny Stocks to Buy Under $1 - Insider Monkey

Investors are optimistic as we move into the third quarter earnings season.

United statesCatherined woodNeil hennessyShannon saccociaAdam morgan velanDerrick tang kynamAaron cowen suvrettaJasper therapeutics incChimerix incNumber of hedge fund holdersKezar life sciences incAmarin corporationGossamer bio incInvitae corpCellular biomedicine group incInvitae corporation

Gossamer Bio, Inc (NASDAQ:GOSS) Given Consensus Rating of Hold by Brokerages

Shares of Gossamer Bio, Inc. (NASDAQ:GOSS – Get Free Report) have received a consensus recommendation of “Hold” from the ten analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and four have given a buy recommendation to the company. […]

United statesCapital managementClearstead advisorsGossamer bio incGossamer bioGet free reportForest capital managementGet freeTyrosine kinaseGossamer bio dailyNasdaq goss

Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs

SAN DIEGO (BUSINESS WIRE) $GOSS Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH), today announced that Rainer Zimmermann, MD, has joined the Company as Vice Presi.

United statesRainer zimmermannFaheem hasnainHeart centerUniversity of aachenExchange commissionBio incCph forumUniversity of oxfordCompany as viceUniversity of giessenGossamer bioVice presidentGlobal medical leadMedical affairsPulmonary hypertension

Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs

Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Rainer zimmermannFaheem hasnainUniversity of giessenUniversity of aachenCph forumCompany as viceUniversity of oxfordHeart centerGossamer bio incGossamer bioVice presidentGlobal medical leadMedical affairsPulmonary hypertensionJohnson innovative

Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension , today announced.

United statesRainer zimmermannFaheem hasnainCph forumUniversity of oxfordGossamer bio incUniversity of giessenCompany as viceExchange commissionUniversity of aachenHeart centerGossamer bioVice presidentGlobal medical leadMedical affairsPulmonary hypertension